Member Info for ParanoiaBlue

of an upward breakout before long??!!

Following on from your comment re: AZM on BRR. I’m in at around the same SP. I couldn’t believe the cave in of the SP, recently. However, I’m sitting tight for now. I think – off the top of my head – that they have adequate funding for the next couple of years. I also take heart from the recent PTI surge upwards on takeover talk [although it has settled back a little for now – awaiting any further news]. However, here again, I’m not buying in any more for now.

Protherics pipeline continues to grow. “Protherics has added to a growing list of drugs in mid-stage clinical trials, announcing that its chemotherapy drug for liver cancer sufferers, Prolarix, is entering a proof of concept study. Protherics now has several drugs in development and existing sales from critical care products CroFab and DigiFab in the US. But all eyes are on whether or not its nascent bid talks will led to a concrete offer. Paul Cuddon of KBC Peel Hunt thinks not, pointing to the failure of any bid to emerge for Meldex as an example of the risk investors face. At 52p, await development from bid talks.”

Is this just an over-reaction in the light of Invesco selling? I would have thought that other "big boy" buys would have compensated this :(

They certainly have not "set the heather on fire!" SP dropping like a stone, for now. On outlook, Tim McCarthy, CEO, said: “Alizyme looks to build on the commercial and clinical progress achieved during the first half of the year as discussions with potential partners in relation to all products in our portfolio continue. Further license opportunities are being pursued with the objective of building multiple revenue streams and leveraging off the virtual business model.” Hmmm!!

Open offer, now past "expected close date" of 26th Aug. I didn't take it up. So I wonder what the next move will be?

Bit of “slip-sliding” going on here. We need to be, keenly, kept aware of how things are progressing. If not, this one is going to continue to precipitate to the bottom of the test-tube.

I am starting to feel that AZM may wallow in these nether regions for some time, or at least until there is some reasonably strong, positive news. The sooner, the better!

Lot of early activity, but appears to have lost steam. Never mind, still in positive territory :) This has got to get back to a sensible price before much longer.

This is what we need. Massive overhang BUYS today! Sense returns!

good buying here today!

From John Stepek, Money Morning It’s been a great couple of months for biotech stocks…….. Meanwhile both Protherics and Oxford Biomedica, a couple of other small pharma stocks, have revealed bid approaches. I hold both Protherics and Acambis in my own portfolio, and they’re stocks I’ve tipped in the past. However, just to demonstrate what a volatile sector biotech can be, when I last tipped Protherics in MoneyWeek in February, the shares were trading at around 50p. By the time the bid news had came around, they had slipped – for no particular reason – to as low as 27p at one point. They’re now at around 56p – but that’s a lot of volatility to endure for a 10% gain or so. What does this show (apart from that share tipping is a mug’s game)? Well, while anyone who bought Protherics at the low has now doubled their money, the chances of most of us getting that lucky are low. And even if you do it once, chances are the next biotech you stick your money into will turn out to be a complete dud. As Andy Smith, manager of the Axa Framlington Biotech fund, told me last week: “I see 400 companies a year. Every one of their chief executives reckons they’ve got a $1bn product.” That’s what’s known as a blockbuster in the pharma trade. But “the truth is that most drugs fail.”

Is that Standard Life Investments buying another 350,000 shares yesterday?

Was hoping for some upward influence on GFM, with miners – ENRC, BHP Billiton, Xstrata, Rio Tinto, Anglo American and Antofagasta – all rising positively!

to the "expected close" on 26th Aug. of the open offer @ 2.5p per share. I note that there is one broker's recommendation to buy this share...........hmmm!

...a slight upward movement, on the back of the decent BUY today!

With an interest in VIA. This is one of the “sleepers” in my portfolio. Just had a quick check around their web-site - http://www.vianet.co.uk – seems positive enough [don’t they al!] Is this “the road to ruin” or the “via to value” ?

Thanks for that post. I think that PTI will be "hovering mode" for now. I can’t see much breakout from here, until we get some clarification on the various TO potentials

...again slowly, let's hope this is some sort of recovery! :)

I'm holding for now - with the thought of a "reasonably positive" outlook! Let's see what develops!?